1. Home
  2. GSAT vs HALO Comparison

GSAT vs HALO Comparison

Compare GSAT & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globalstar Inc.

GSAT

Globalstar Inc.

HOLD

Current Price

$53.97

Market Cap

8.2B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$78.37

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSAT
HALO
Founded
2003
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.8B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
GSAT
HALO
Price
$53.97
$78.37
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$52.75
$76.42
AVG Volume (30 Days)
693.6K
1.8M
Earning Date
02-26-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
56.68
EPS
N/A
4.74
Revenue
$262,202,000.00
$1,242,852,000.00
Revenue This Year
$10.93
$34.54
Revenue Next Year
$10.72
$26.28
P/E Ratio
N/A
$16.45
Revenue Growth
8.54
31.19
52 Week Low
$17.24
$47.50
52 Week High
$74.88
$79.50

Technical Indicators

Market Signals
Indicator
GSAT
HALO
Relative Strength Index (RSI) 37.79 69.66
Support Level $60.21 $71.23
Resistance Level $63.00 $74.48
Average True Range (ATR) 4.68 2.31
MACD -0.85 0.63
Stochastic Oscillator 0.47 91.84

Price Performance

Historical Comparison
GSAT
HALO

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: